RMM
10
35M
4
3
0.60
1
- Stages of investment
- Areas of investment
Summary
The venture was found in Europe in Belgium. The main department of described VC is located in the Gent.
The fund was created by Rudi M. Marien.
For fund there is no match between the location of its establishment and the land of its numerous investments - Ireland. Among the most popular portfolio startups of the fund, we may highlight JenaValve Technology, 4Tech, Biocartis. Among the most popular fund investment industries, there are Manufacturing, Health Care. The fund has specific favorite in a number of founders of portfolio startups. Besides, a startup needs to be aged 6-10 years to get the investment from the fund.
The standard case for the fund is to invest in rounds with 7-8 partakers. Despite the RMM, startups are often financed by VI Partners AG, Sunstone Life Science Ventures, Neomed Management. The meaningful sponsors for the fund in investment in the same round are Valiance Asset Management, Neomed Management, Valiance Solutions. In the next rounds fund is usually obtained by PMV Tina Fund, Johnson & Johnson Development Corporation, Wellcome Trust.
The real fund results show that this VC is 40 percentage points more often commits exit comparing to other companies. The fund is constantly included in less than 2 deals per year. Comparing to the other companies, this RMM performs on 9 percentage points less the average number of lead investments. The top amount of exits for fund were in 2015. The usual things for fund are deals in the range of 10 - 50 millions dollars. The important activity for fund was in 2016.
Investments analytics
Analytics
- Total investments
- 10
- Lead investments
- 3
- Exits
- 1
- Follow on index
- 0.60
- Investments by industry
- Medical Device (8)
- Health Care (5)
- Medical (5)
- Biotechnology (4)
- Health Diagnostics (2) Show 1 more
- Investments by region
-
- Germany (5)
- Switzerland (2)
- Ireland (1)
- Peak activity year
- 2020
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 10
- Avg. valuation at time of investment
- 132M
- Group Appearance index
- 1.00
- Strategy success index
- 0.50
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| JenaValve Technology | 31 Aug 2022 | Health Care, Medical Device, Medical | Late Stage Venture | 100M | Munich, Bavaria, Germany |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.